BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 416 hits from BIOMARIN PHARMACEUTICAL INC.   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Histone deacetylase


(Homo sapiens (human))
BDBM50005711
PNG
(CHEBI:46024 | GNF-Pf-1011 | TRICHOSTATIN | Trichos...)
Show SMILES C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C
Show InChI InChI=1S/C17H22N2O3/c1-12(5-10-16(20)18-22)11-13(2)17(21)14-6-8-15(9-7-14)19(3)4/h5-11,13,22H,1-4H3,(H,18,20)/b10-5+,12-11+/t13-/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
GoogleScholar
AffyNet 
Purchase

DrugBank
PC cid
PC sid
PDB
UniChem
US Patent
n/an/a 1.40n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (human))
BDBM50005711
PNG
(CHEBI:46024 | GNF-Pf-1011 | TRICHOSTATIN | Trichos...)
Show SMILES C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C
Show InChI InChI=1S/C17H22N2O3/c1-12(5-10-16(20)18-22)11-13(2)17(21)14-6-8-15(9-7-14)19(3)4/h5-11,13,22H,1-4H3,(H,18,20)/b10-5+,12-11+/t13-/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
Purchase

DrugBank
PC cid
PC sid
PDB
UniChem
US Patent
n/an/a 6.70n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM50005711
PNG
(CHEBI:46024 | GNF-Pf-1011 | TRICHOSTATIN | Trichos...)
Show SMILES C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C
Show InChI InChI=1S/C17H22N2O3/c1-12(5-10-16(20)18-22)11-13(2)17(21)14-6-8-15(9-7-14)19(3)4/h5-11,13,22H,1-4H3,(H,18,20)/b10-5+,12-11+/t13-/m1/s1
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
Purchase

DrugBank
PC cid
PC sid
PDB
UniChem
US Patent
n/an/a 9.60n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 1/3/5/8


(Homo sapiens (Human))
BDBM50005711
PNG
(CHEBI:46024 | GNF-Pf-1011 | TRICHOSTATIN | Trichos...)
Show SMILES C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C
Show InChI InChI=1S/C17H22N2O3/c1-12(5-10-16(20)18-22)11-13(2)17(21)14-6-8-15(9-7-14)19(3)4/h5-11,13,22H,1-4H3,(H,18,20)/b10-5+,12-11+/t13-/m1/s1
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
Purchase

DrugBank
PC cid
PC sid
PDB
UniChem
US Patent
n/an/a 12.5n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase


(Homo sapiens (human))
BDBM50005711
PNG
(CHEBI:46024 | GNF-Pf-1011 | TRICHOSTATIN | Trichos...)
Show SMILES C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C
Show InChI InChI=1S/C17H22N2O3/c1-12(5-10-16(20)18-22)11-13(2)17(21)14-6-8-15(9-7-14)19(3)4/h5-11,13,22H,1-4H3,(H,18,20)/b10-5+,12-11+/t13-/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
Purchase

DrugBank
PC cid
PC sid
PDB
UniChem
US Patent
n/an/a 14.8n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207746
PNG
(US9265734, R26)
Show SMILES Nc1ccccc1NC(=O)CCCCCNC(=O)c1cc2cc(Cl)ccc2[nH]1
Show InChI InChI=1S/C21H23ClN4O2/c22-15-9-10-17-14(12-15)13-19(25-17)21(28)24-11-5-1-2-8-20(27)26-18-7-4-3-6-16(18)23/h3-4,6-7,9-10,12-13,25H,1-2,5,8,11,23H2,(H,24,28)(H,26,27)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 20n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207743
PNG
(US9265734, R23)
Show SMILES Nc1ccccc1NC(=O)CCCCCNC(=O)c1cc2cc(OC(F)(F)F)ccc2[nH]1
Show InChI InChI=1S/C22H23F3N4O3/c23-22(24,25)32-15-9-10-17-14(12-15)13-19(28-17)21(31)27-11-5-1-2-8-20(30)29-18-7-4-3-6-16(18)26/h3-4,6-7,9-10,12-13,28H,1-2,5,8,11,26H2,(H,27,31)(H,29,30)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 20n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (human))
BDBM207650
PNG
(US9265734, R130)
Show SMILES Nc1ccc(cc1NC(=O)CCCCCCNC(=O)c1cccnc1)-c1cccs1
Show InChI InChI=1S/C23H26N4O2S/c24-19-11-10-17(21-8-6-14-30-21)15-20(19)27-22(28)9-3-1-2-4-13-26-23(29)18-7-5-12-25-16-18/h5-8,10-12,14-16H,1-4,9,13,24H2,(H,26,29)(H,27,28)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 21n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone Deacetylase 10 (HDAC10)


(Homo sapiens (human))
BDBM50005711
PNG
(CHEBI:46024 | GNF-Pf-1011 | TRICHOSTATIN | Trichos...)
Show SMILES C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C
Show InChI InChI=1S/C17H22N2O3/c1-12(5-10-16(20)18-22)11-13(2)17(21)14-6-8-15(9-7-14)19(3)4/h5-11,13,22H,1-4H3,(H,18,20)/b10-5+,12-11+/t13-/m1/s1
NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
Purchase

DrugBank
PC cid
PC sid
PDB
UniChem
US Patent
n/an/a 22.8n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207811
PNG
(US9265734, R92)
Show SMILES COc1ccc2cc([nH]c2c1)C(=O)NCCCCCC(=O)Nc1ccccc1N
Show InChI InChI=1S/C22H26N4O3/c1-29-16-11-10-15-13-20(25-19(15)14-16)22(28)24-12-6-2-3-9-21(27)26-18-8-5-4-7-17(18)23/h4-5,7-8,10-11,13-14,25H,2-3,6,9,12,23H2,1H3,(H,24,28)(H,26,27)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 26n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207744
PNG
(US9265734, R24)
Show SMILES Cc1ccc2[nH]c(cc2c1)C(=O)NCCCCCC(=O)Nc1ccccc1N
Show InChI InChI=1S/C22H26N4O2/c1-15-10-11-18-16(13-15)14-20(25-18)22(28)24-12-6-2-3-9-21(27)26-19-8-5-4-7-17(19)23/h4-5,7-8,10-11,13-14,25H,2-3,6,9,12,23H2,1H3,(H,24,28)(H,26,27)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 27n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207742
PNG
(US9265734, R22)
Show SMILES Nc1ccccc1NC(=O)CCCCCNC(=O)c1cc2c(Cl)cccc2[nH]1
Show InChI InChI=1S/C21H23ClN4O2/c22-15-7-6-10-17-14(15)13-19(25-17)21(28)24-12-5-1-2-11-20(27)26-18-9-4-3-8-16(18)23/h3-4,6-10,13,25H,1-2,5,11-12,23H2,(H,24,28)(H,26,27)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 28n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207704
PNG
(BDBM207788 | US9265734, R184)
Show SMILES Nc1ccccc1NC(=O)CCCCCNC(=O)c1ccc2[nH]ccc2c1
Show InChI InChI=1S/C21H24N4O2/c22-17-6-3-4-7-19(17)25-20(26)8-2-1-5-12-24-21(27)16-9-10-18-15(14-16)11-13-23-18/h3-4,6-7,9-11,13-14,23H,1-2,5,8,12,22H2,(H,24,27)(H,25,26)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 31n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207705
PNG
(US9265734, R185)
Show SMILES COc1ccc2[nH]c(cc2c1)C(=O)NCCCCCC(=O)Nc1ccccc1N
Show InChI InChI=1S/C22H26N4O3/c1-29-16-10-11-18-15(13-16)14-20(25-18)22(28)24-12-6-2-3-9-21(27)26-19-8-5-4-7-17(19)23/h4-5,7-8,10-11,13-14,25H,2-3,6,9,12,23H2,1H3,(H,24,28)(H,26,27)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 31n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207748
PNG
(US9265734, R28)
Show SMILES Cc1cccc2cc([nH]c12)C(=O)NCCCCCC(=O)Nc1ccccc1N
Show InChI InChI=1S/C22H26N4O2/c1-15-8-7-9-16-14-19(26-21(15)16)22(28)24-13-6-2-3-12-20(27)25-18-11-5-4-10-17(18)23/h4-5,7-11,14,26H,2-3,6,12-13,23H2,1H3,(H,24,28)(H,25,27)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 32n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207815
PNG
(US9265734, R96)
Show SMILES Cc1ccc2cc([nH]c2c1)C(=O)NCCCCCC(=O)Nc1ccccc1N
Show InChI InChI=1S/C22H26N4O2/c1-15-10-11-16-14-20(25-19(16)13-15)22(28)24-12-6-2-3-9-21(27)26-18-8-5-4-7-17(18)23/h4-5,7-8,10-11,13-14,25H,2-3,6,9,12,23H2,1H3,(H,24,28)(H,26,27)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 32n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207703
PNG
(US9265734, R183)
Show SMILES Nc1ccccc1NC(=O)CCCCCNC(=O)c1cc2ccccc2[nH]1
Show InChI InChI=1S/C21H24N4O2/c22-16-9-4-6-11-18(16)25-20(26)12-2-1-7-13-23-21(27)19-14-15-8-3-5-10-17(15)24-19/h3-6,8-11,14,24H,1-2,7,12-13,22H2,(H,23,27)(H,25,26)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 33n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207789
PNG
(US9265734, R70)
Show SMILES Cn1ccc2cc(ccc12)C(=O)NCCCCCC(=O)Nc1ccccc1N
Show InChI InChI=1S/C22H26N4O2/c1-26-14-12-16-15-17(10-11-20(16)26)22(28)24-13-6-2-3-9-21(27)25-19-8-5-4-7-18(19)23/h4-5,7-8,10-12,14-15H,2-3,6,9,13,23H2,1H3,(H,24,28)(H,25,27)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 33n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207781
PNG
(US9265734, R62)
Show SMILES Nc1ccccc1NC(=O)CCCCCNC(=O)c1c[nH]c2ccccc12
Show InChI InChI=1S/C21H24N4O2/c22-17-9-4-6-11-19(17)25-20(26)12-2-1-7-13-23-21(27)16-14-24-18-10-5-3-8-15(16)18/h3-6,8-11,14,24H,1-2,7,12-13,22H2,(H,23,27)(H,25,26)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 33n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 4


(Homo sapiens (Human))
BDBM50005711
PNG
(CHEBI:46024 | GNF-Pf-1011 | TRICHOSTATIN | Trichos...)
Show SMILES C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C
Show InChI InChI=1S/C17H22N2O3/c1-12(5-10-16(20)18-22)11-13(2)17(21)14-6-8-15(9-7-14)19(3)4/h5-11,13,22H,1-4H3,(H,18,20)/b10-5+,12-11+/t13-/m1/s1
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
Purchase

DrugBank
PC cid
PC sid
PDB
UniChem
US Patent
n/an/a 34.8n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207769
PNG
(US9265734, R49)
Show SMILES Nc1ccccc1NC(=O)CCCCCNC(=O)c1c[nH]c2c(Cl)cccc12
Show InChI InChI=1S/C21H23ClN4O2/c22-16-8-6-7-14-15(13-25-20(14)16)21(28)24-12-5-1-2-11-19(27)26-18-10-4-3-9-17(18)23/h3-4,6-10,13,25H,1-2,5,11-12,23H2,(H,24,28)(H,26,27)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 35n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207739
PNG
(US9265734, R19)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)NCCCCCC(=O)Nc1ccccc1N
Show InChI InChI=1S/C22H26N4O3/c1-29-20-11-7-10-17-15(20)14-19(25-17)22(28)24-13-6-2-3-12-21(27)26-18-9-5-4-8-16(18)23/h4-5,7-11,14,25H,2-3,6,12-13,23H2,1H3,(H,24,28)(H,26,27)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 36n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207809
PNG
(US9265734, R90)
Show SMILES Nc1ccccc1NC(=O)CCCCCNC(=O)c1cccc2cc[nH]c12
Show InChI InChI=1S/C21H24N4O2/c22-17-9-3-4-10-18(17)25-19(26)11-2-1-5-13-24-21(27)16-8-6-7-15-12-14-23-20(15)16/h3-4,6-10,12,14,23H,1-2,5,11,13,22H2,(H,24,27)(H,25,26)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 36n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207817
PNG
(US9265734, R98)
Show SMILES Cc1[nH]c2cc(ccc2c1C)C(=O)NCCCCCC(=O)Nc1ccccc1N
Show InChI InChI=1S/C23H28N4O2/c1-15-16(2)26-21-14-17(11-12-18(15)21)23(29)25-13-7-3-4-10-22(28)27-20-9-6-5-8-19(20)24/h5-6,8-9,11-12,14,26H,3-4,7,10,13,24H2,1-2H3,(H,25,29)(H,27,28)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 37n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207785
PNG
(US9265734, R66)
Show SMILES COc1ccc2c(c[nH]c2c1)C(=O)NCCCCCC(=O)Nc1ccccc1N
Show InChI InChI=1S/C22H26N4O3/c1-29-15-10-11-16-17(14-25-20(16)13-15)22(28)24-12-6-2-3-9-21(27)26-19-8-5-4-7-18(19)23/h4-5,7-8,10-11,13-14,25H,2-3,6,9,12,23H2,1H3,(H,24,28)(H,26,27)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 38n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207782
PNG
(US9265734, R63)
Show SMILES COc1ccc2[nH]cc(C(=O)NCCCCCC(=O)Nc3ccccc3N)c2c1
Show InChI InChI=1S/C22H26N4O3/c1-29-15-10-11-19-16(13-15)17(14-25-19)22(28)24-12-6-2-3-9-21(27)26-20-8-5-4-7-18(20)23/h4-5,7-8,10-11,13-14,25H,2-3,6,9,12,23H2,1H3,(H,24,28)(H,26,27)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 39n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207738
PNG
(US9265734, R18)
Show SMILES Cc1c([nH]c2ccccc12)C(=O)NCCCCCC(=O)Nc1ccccc1N
Show InChI InChI=1S/C22H26N4O2/c1-15-16-9-4-6-11-18(16)26-21(15)22(28)24-14-8-2-3-13-20(27)25-19-12-7-5-10-17(19)23/h4-7,9-12,26H,2-3,8,13-14,23H2,1H3,(H,24,28)(H,25,27)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 40n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207749
PNG
(US9265734, R29)
Show SMILES Nc1ccccc1NC(=O)CCCCCNC(=O)c1cc2cccc(F)c2[nH]1
Show InChI InChI=1S/C21H23FN4O2/c22-15-8-6-7-14-13-18(26-20(14)15)21(28)24-12-5-1-2-11-19(27)25-17-10-4-3-9-16(17)23/h3-4,6-10,13,26H,1-2,5,11-12,23H2,(H,24,28)(H,25,27)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 41n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207820
PNG
(US9265734, R101)
Show SMILES Nc1ccccc1NC(=O)CCCCCNC(=O)c1ccc2cc[nH]c2c1
Show InChI InChI=1S/C21H24N4O2/c22-17-6-3-4-7-18(17)25-20(26)8-2-1-5-12-24-21(27)16-10-9-15-11-13-23-19(15)14-16/h3-4,6-7,9-11,13-14,23H,1-2,5,8,12,22H2,(H,24,27)(H,25,26)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 41n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (human))
BDBM207751
PNG
(US9265734, R31)
Show SMILES Nc1ccccc1NC(=O)CCCCCNC(=O)c1cc2c(OC(F)F)cccc2[nH]1
Show InChI InChI=1S/C22H24F2N4O3/c23-22(24)31-19-10-6-9-16-14(19)13-18(27-16)21(30)26-12-5-1-2-11-20(29)28-17-8-4-3-7-15(17)25/h3-4,6-10,13,22,27H,1-2,5,11-12,25H2,(H,26,30)(H,28,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 41n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207768
PNG
(US9265734, R48)
Show SMILES Cc1[nH]c2ccc(cc2c1C)C(=O)NCCCCCC(=O)Nc1ccccc1N
Show InChI InChI=1S/C23H28N4O2/c1-15-16(2)26-20-12-11-17(14-18(15)20)23(29)25-13-7-3-4-10-22(28)27-21-9-6-5-8-19(21)24/h5-6,8-9,11-12,14,26H,3-4,7,10,13,24H2,1-2H3,(H,25,29)(H,27,28)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 41n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207818
PNG
(US9265734, R99)
Show SMILES Cc1ccc2[nH]nc(C(=O)NCCCCCC(=O)Nc3ccccc3N)c2c1
Show InChI InChI=1S/C21H25N5O2/c1-14-10-11-17-15(13-14)20(26-25-17)21(28)23-12-6-2-3-9-19(27)24-18-8-5-4-7-16(18)22/h4-5,7-8,10-11,13H,2-3,6,9,12,22H2,1H3,(H,23,28)(H,24,27)(H,25,26)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 45n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207760
PNG
(US9265734, R40)
Show SMILES COc1cccc2c(c[nH]c12)C(=O)NCCCCCC(=O)Nc1ccccc1N
Show InChI InChI=1S/C22H26N4O3/c1-29-19-11-7-8-15-16(14-25-21(15)19)22(28)24-13-6-2-3-12-20(27)26-18-10-5-4-9-17(18)23/h4-5,7-11,14,25H,2-3,6,12-13,23H2,1H3,(H,24,28)(H,26,27)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 46n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207762
PNG
(US9265734, R42)
Show SMILES Cc1[nH]c2c(cccc2c1C)C(=O)NCCCCCC(=O)Nc1ccccc1N
Show InChI InChI=1S/C23H28N4O2/c1-15-16(2)26-22-17(15)9-8-10-18(22)23(29)25-14-7-3-4-13-21(28)27-20-12-6-5-11-19(20)24/h5-6,8-12,26H,3-4,7,13-14,24H2,1-2H3,(H,25,29)(H,27,28)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 47n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207819
PNG
(US9265734, R100)
Show SMILES Nc1ccccc1NC(=O)CCCCCNC(=O)c1c[nH]c2ccc(Cl)cc12
Show InChI InChI=1S/C21H23ClN4O2/c22-14-9-10-18-15(12-14)16(13-25-18)21(28)24-11-5-1-2-8-20(27)26-19-7-4-3-6-17(19)23/h3-4,6-7,9-10,12-13,25H,1-2,5,8,11,23H2,(H,24,28)(H,26,27)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 48n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207766
PNG
(US9265734, R46)
Show SMILES CCOc1ccc2[nH]c(cc2c1)C(=O)NCCCCCC(=O)Nc1ccccc1N
Show InChI InChI=1S/C23H28N4O3/c1-2-30-17-11-12-19-16(14-17)15-21(26-19)23(29)25-13-7-3-4-10-22(28)27-20-9-6-5-8-18(20)24/h5-6,8-9,11-12,14-15,26H,2-4,7,10,13,24H2,1H3,(H,25,29)(H,27,28)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 49n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207751
PNG
(US9265734, R31)
Show SMILES Nc1ccccc1NC(=O)CCCCCNC(=O)c1cc2c(OC(F)F)cccc2[nH]1
Show InChI InChI=1S/C22H24F2N4O3/c23-22(24)31-19-10-6-9-16-14(19)13-18(27-16)21(30)26-12-5-1-2-11-20(29)28-17-8-4-3-7-15(17)25/h3-4,6-10,13,22,27H,1-2,5,11-12,25H2,(H,26,30)(H,28,29)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 52n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207790
PNG
(US9265734, R71)
Show SMILES Cn1nc(C(=O)NCCCCCC(=O)Nc2ccccc2N)c2ccccc12
Show InChI InChI=1S/C21H25N5O2/c1-26-18-12-7-4-9-15(18)20(25-26)21(28)23-14-8-2-3-13-19(27)24-17-11-6-5-10-16(17)22/h4-7,9-12H,2-3,8,13-14,22H2,1H3,(H,23,28)(H,24,27)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 54n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207747
PNG
(US9265734, R27)
Show SMILES COc1cccc2cc([nH]c12)C(=O)NCCCCCC(=O)Nc1ccccc1N
Show InChI InChI=1S/C22H26N4O3/c1-29-19-11-7-8-15-14-18(26-21(15)19)22(28)24-13-6-2-3-12-20(27)25-17-10-5-4-9-16(17)23/h4-5,7-11,14,26H,2-3,6,12-13,23H2,1H3,(H,24,28)(H,25,27)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 55n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207765
PNG
(US9265734, R45)
Show SMILES Cn1cc(C(=O)NCCCCCC(=O)Nc2ccccc2N)c2ccccc12
Show InChI InChI=1S/C22H26N4O2/c1-26-15-17(16-9-4-7-12-20(16)26)22(28)24-14-8-2-3-13-21(27)25-19-11-6-5-10-18(19)23/h4-7,9-12,15H,2-3,8,13-14,23H2,1H3,(H,24,28)(H,25,27)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 56n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207745
PNG
(US9265734, R25)
Show SMILES Nc1ccccc1NC(=O)CCCCCNC(=O)c1cc2cc(F)ccc2[nH]1
Show InChI InChI=1S/C21H23FN4O2/c22-15-9-10-17-14(12-15)13-19(25-17)21(28)24-11-5-1-2-8-20(27)26-18-7-4-3-6-16(18)23/h3-4,6-7,9-10,12-13,25H,1-2,5,8,11,23H2,(H,24,28)(H,26,27)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 57n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207704
PNG
(BDBM207788 | US9265734, R184)
Show SMILES Nc1ccccc1NC(=O)CCCCCNC(=O)c1ccc2[nH]ccc2c1
Show InChI InChI=1S/C21H24N4O2/c22-17-6-3-4-7-19(17)25-20(26)8-2-1-5-12-24-21(27)16-9-10-18-15(14-16)11-13-23-18/h3-4,6-7,9-11,13-14,23H,1-2,5,8,12,22H2,(H,24,27)(H,25,26)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 57n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207755
PNG
(US9265734, R35)
Show SMILES Cn1c(cc2cc(Cl)ccc12)C(=O)NCCCCCC(=O)Nc1ccccc1N
Show InChI InChI=1S/C22H25ClN4O2/c1-27-19-11-10-16(23)13-15(19)14-20(27)22(29)25-12-6-2-3-9-21(28)26-18-8-5-4-7-17(18)24/h4-5,7-8,10-11,13-14H,2-3,6,9,12,24H2,1H3,(H,25,29)(H,26,28)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 58n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207771
PNG
(US9265734, R52)
Show SMILES Cc1cccc(c1)C(=O)NCCCCCC(=O)Nc1ccccc1N
Show InChI InChI=1S/C20H25N3O2/c1-15-8-7-9-16(14-15)20(25)22-13-6-2-3-12-19(24)23-18-11-5-4-10-17(18)21/h4-5,7-11,14H,2-3,6,12-13,21H2,1H3,(H,22,25)(H,23,24)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 58n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207808
PNG
(US9265734, R89)
Show SMILES COc1cccc2[nH]cc(C(=O)NCCCCCC(=O)Nc3ccccc3N)c12
Show InChI InChI=1S/C22H26N4O3/c1-29-19-11-7-10-18-21(19)15(14-25-18)22(28)24-13-6-2-3-12-20(27)26-17-9-5-4-8-16(17)23/h4-5,7-11,14,25H,2-3,6,12-13,23H2,1H3,(H,24,28)(H,26,27)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 58n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (human))
BDBM207748
PNG
(US9265734, R28)
Show SMILES Cc1cccc2cc([nH]c12)C(=O)NCCCCCC(=O)Nc1ccccc1N
Show InChI InChI=1S/C22H26N4O2/c1-15-8-7-9-16-14-19(26-21(15)16)22(28)24-13-6-2-3-12-20(27)25-18-11-5-4-10-17(18)23/h4-5,7-11,14,26H,2-3,6,12-13,23H2,1H3,(H,24,28)(H,25,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 59n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207741
PNG
(US9265734, R21)
Show SMILES Nc1ccccc1NC(=O)CCCCCNC(=O)c1cc2c(F)cccc2[nH]1
Show InChI InChI=1S/C21H23FN4O2/c22-15-7-6-10-17-14(15)13-19(25-17)21(28)24-12-5-1-2-11-20(27)26-18-9-4-3-8-16(18)23/h3-4,6-10,13,25H,1-2,5,11-12,23H2,(H,24,28)(H,26,27)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 60n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (human))
BDBM207755
PNG
(US9265734, R35)
Show SMILES Cn1c(cc2cc(Cl)ccc12)C(=O)NCCCCCC(=O)Nc1ccccc1N
Show InChI InChI=1S/C22H25ClN4O2/c1-27-19-11-10-16(23)13-15(19)14-20(27)22(29)25-12-6-2-3-9-21(28)26-18-8-5-4-7-17(18)24/h4-5,7-8,10-11,13-14H,2-3,6,9,12,24H2,1H3,(H,25,29)(H,26,28)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 61n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 3/NCoR1


(Homo sapiens (human))
BDBM207776
PNG
(US9265734, R57)
Show SMILES CN1CCN(CC1)c1cccc(c1)C(=O)NCCCCCC(=O)Nc1ccccc1N
Show InChI InChI=1S/C24H33N5O2/c1-28-14-16-29(17-15-28)20-9-7-8-19(18-20)24(31)26-13-6-2-3-12-23(30)27-22-11-5-4-10-21(22)25/h4-5,7-11,18H,2-3,6,12-17,25H2,1H3,(H,26,31)(H,27,30)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 66n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (human))
BDBM207649
PNG
(US9265734, R129)
Show SMILES Nc1ccc(cc1NC(=O)CCCCCCNC(=O)c1cccnc1)-c1ccccc1
Show InChI InChI=1S/C25H28N4O2/c26-22-14-13-20(19-9-4-3-5-10-19)17-23(22)29-24(30)12-6-1-2-7-16-28-25(31)21-11-8-15-27-18-21/h3-5,8-11,13-15,17-18H,1-2,6-7,12,16,26H2,(H,28,31)(H,29,30)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 66n/an/an/an/an/an/a



BIOMARIN PHARMACEUTICAL INC.

US Patent


Assay Description
HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...


US Patent US9265734 (2016)


BindingDB Entry DOI: 10.7270/Q2BK1B5B
More data for this
Ligand-Target Pair
Displayed 1 to 50 (of 416 total )  |  Next  |  Last  >>
Jump to: